Managing Patients with Lung Cancer - October Session is organized by The University of Chicago and would be held on Oct 15, 2016 at Gleacher Center, Chicago, Illinois, United States Of America. The Targeted Audience for this medical event is basically for thoracic surgeons, pulmonologists, oncologists, radiation oncologists, and pathologists involved in the diagnosis and management of patients suffering from lung cancer. This CME conference has been approved with 6.5 AMA PRA Category 1 Credits.
At the conclusion of this activity, the learner will be able to :
* Define the use of advanced bronchoscopic techniques, transthoracic needle aspiration or surgery for diagnosis and molecular testing of lung cancer
* Outline the positive and negative aspects of endobronchial ultrasound transbronchial needle aspiration and mediastinoscopy for staging and molecular testing
* Define the role of video assisted and robotic surgery for diagnosis and curative intent treatment of lung cancer
* Summarize the evidence of conventional and stereotactic ablative radiotherapy for lung cancer and oligo-metastatic disease
* State the immunohistochemistry panels and molecular markers relevant for histologic diagnosis and targeted therapy
* List the benefits and adverse effects of conventional chemotherapy, biologic agents, and immunotherapy drugs for advanced lung cancer.